Newspaper publication of Unaudited financial result for the quarter ended on June 30, 2025 is attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories Limited has submitted the newspaper publication of its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) to BSE on August 14, 2025, as required under SEBI (LODR) Regulation 47. The results were published in Active Times (English) and Mumbai Lakshdeep (Marathi), with a QR code linking to the full disclosure. Total income from operations rose to about Rs. 1,813.54 lakhs from Rs. 1,667.66 lakhs in Q1 FY25 (around 9% YoY growth). Net profit before tax climbed to about Rs. 154.73 lakhs from Rs. 91.93 lakhs (roughly 68% YoY), while net profit after tax jumped to about Rs. 97.6 lakhs from Rs. 34.15 lakhs (roughly 186% YoY). Basic and diluted EPS stood at Rs. 8.06 versus Rs. 2.85 in the year-ago quarter. The company operates in a single segment – Pharmaceutical Products. Results were reviewed by the Audit Committee and approved by the Board on August 13, 2025.
The filing itself is only a regulatory newspaper publication of already-disclosed Q1 results, so it is unlikely to move the stock on its own. However, the underlying numbers show a sharp jump in profits year-on-year, which is a positive signal for shareholders.